SELPLG (CD162): P-Selectin Glycoprotein Ligand 1
Key mediator of leukocyte tethering and rolling on activated endothelium.
Gene Information Card
| Symbol | SELPLG |
|---|---|
| Full Name | Selectin P Ligand |
| Gene Type | Protein coding |
| Chromosomal Location | 12q24.11 |
| NCBI Gene ID | 6404 ncbi.nlm.nih.gov/gene/6404 |
| Ensembl ID | ENSG00000110848 |
| UniProt ID | Q14242 |
| OMIM ID | 600882 |
| HGNC ID | 10721 |
| Aliases | CD162, PSGL-1, CLA, PSGL1 |
Description
SELPLG encodes P-selectin glycoprotein ligand 1 (PSGL-1), a transmembrane glycoprotein expressed on the surface of most leukocytes. PSGL-1 binds to P-, E-, and L-selectins on activated endothelial cells and platelets, mediating the initial tethering and rolling of leukocytes during inflammation. It also plays roles in lymphocyte homing, platelet-leukocyte interactions, and immune regulation. Alternative splicing generates multiple transcript variants.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Psoriasis | PSGL-1 interaction with E-selectin on dermal endothelium promotes T-cell recruitment to skin lesions. | PMID: 11511316 |
| Atherosclerosis | PSGL-1 mediates monocyte and neutrophil adhesion to activated endothelium, contributing to plaque formation. | PMID: 12566389 |
| Leukocyte adhesion deficiency type II (LAD II) | Defective fucosylation of PSGL-1 impairs selectin binding, causing recurrent infections. | OMIM #266265 |
| Acute respiratory distress syndrome (ARDS) | PSGL-1-dependent neutrophil sequestration in lung microvasculature exacerbates inflammation. | PMID: 11511316 |
| Cancer metastasis | PSGL-1 on tumor cells facilitates adhesion to selectins on endothelium, promoting extravasation. | PMID: 12566389 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Whole blood | 45.2 | High |
| Spleen | 32.1 | High |
| Lung | 18.7 | Medium |
| Bone marrow | 22.5 | Medium |
| Lymph node | 28.3 | Medium |
| Small intestine | 8.9 | Low |
| Brain | 1.2 | Not detected |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| THP-1 (monocyte) | 62.4 | High expression; used in adhesion assays |
| Jurkat (T-cell) | 55.1 | High expression; PSGL-1 functional studies |
| HL-60 (promyeloblast) | 48.7 | High expression; differentiation reduces PSGL-1 |
| K562 (erythroleukemia) | 3.2 | Low expression; negative control |
| HEK293 (embryonic kidney) | 1.8 | Low endogenous expression; used for transfection |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1A>G (p.Met1Val) | Missense | <0.01% | Loss of start codon; predicted loss of protein |
| c.232C>T (p.Arg78Trp) | Missense | <0.01% | Alters ligand binding domain; reduced selectin affinity |
| c.523G>A (p.Gly175Arg) | Missense | <0.01% | Located in extracellular domain; functional impact unknown |
| c.1003C>T (p.Arg335Cys) | Missense | <0.01% | May affect dimerization or stability |
Mutation functional classification
Loss of Function (LOF)
Mutations that disrupt the start codon (p.Met1Val) or critical residues in the N-terminal binding domain (p.Arg78Trp) impair PSGL-1 expression or selectin binding, leading to reduced leukocyte adhesion.
Gain of Function (GOF)
No confirmed gain-of-function mutations reported in SELPLG.
Dominant Negative (DN)
No dominant-negative mutations described for SELPLG.
View complete mutation data:
Gene Ontology (GO)
| • scavenger receptor activity (GO:0005044) | • protein binding (GO:0005515) |
| • plasma membrane (GO:0005886) | • cell adhesion (GO:0007155) |
| • integral component of membrane (GO:0016021) | • cell junction (GO:0030054) |
| • P-selectin binding (GO:0033690) | • leukocyte migration (GO:0050900) |
Pathways
• R-HSA-202733: Cell surface interactions at the vascular wall
• R-HSA-198933: Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
• R-HSA-375276: P-selectin-mediated rolling of leukocytes on endothelium
• R-HSA-202948: E-selectin-mediated rolling of leukocytes on endothelium
• R-HSA-202949: L-selectin-mediated rolling of leukocytes on endothelium
Protein Summary
PSGL-1 is a 402-amino acid type I transmembrane glycoprotein with an N-terminal signal peptide, a mucin-like extracellular domain rich in serine, threonine, and proline residues, a single transmembrane domain, and a short cytoplasmic tail. The extracellular domain contains multiple O-glycosylation sites and a tyrosine sulfation motif critical for high-affinity binding to P-selectin. PSGL-1 forms homodimers via disulfide bonds and is constitutively expressed on all leukocytes. Its cytoplasmic tail interacts with ezrin/radixin/moesin (ERM) proteins, linking to the actin cytoskeleton and regulating cell shape and migration.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SELPLG Knockout HEK293 Cell Line | EDJ-KQ50621 | Human | 6404 | Details Get a Quote |
| SELPLG Knockout HeLa Cell Line | EDJ-KQ54441 | Human | 6404 | Details Get a Quote |
| SELPLG Knockout A-549 Cell Line | EDJ-KQ62932 | Human | 6404 | Details Get a Quote |
| SELPLG Knockout HCT 116 Cell Line | EDJ-KQ71401 | Human | 6404 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records